Registry for inflammatory bowel disease in southeastern Korea
Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea
This study is collecting information from patients with Crohn's disease and ulcerative colitis in southeastern Korea to see how these conditions develop and change over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Kyungpook National University Hospital Academic / other |
| Locations | 1 site (Daegu) |
| Trial ID | NCT02193464 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the incidence and natural progression of idiopathic chronic inflammatory bowel disease, including Crohn's disease and ulcerative colitis, in the Daegu-Gyeongbuk region of Korea. By collecting data from patients diagnosed with these conditions and followed for at least six months, the study seeks to provide insights into the disease's characteristics and trends in this specific geographic area. The findings may help improve understanding and management of inflammatory bowel disease in the region.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with inflammatory bowel disease who have been monitored for at least six months and reside in the Daegu-Gyeongbuk province.
Not a fit: Patients living outside the Daegu-Gyeongbuk province will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of inflammatory bowel disease, leading to better diagnosis and treatment strategies for patients.
How similar studies have performed: While similar registries have been established in other regions, this specific study is novel in its focus on the southeastern area of Korea.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis * Followed up for at least 6 months for the correct diagnosis Exclusion Criteria: * Patients who do not live in Daegu-Gyeongbuk province
Where this trial is running
Daegu
- Keimyung University Dongsan Medical Center — Daegu, South Korea (Recruiting)
Study contacts
- Principal investigator: Eun Soo Kim, MD, PhD — Keimyung University School of Medicine
- Study coordinator: Eun Soo Kim, MD. PhD
- Email: dandy813@hanmail.net
- Phone: +82-53-250-7088
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.